Metraipolis › archive › dc_ae3595c71be2

Genomics-driven drug repurposing and novel targets identification for sickle cell disease in Saudi patients — Europe PMC PMID:41409427

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41409427
DOI
10.3389/fbinf.2025.1671626
License (as archived)
solo-consultazione
Archived
2026-11-08T00:49:42.853Z
SHA-256 of the archived text
cf9dce638c531b769856ee1502380e0a602de6a610d623fb767661402537e6c2
Stable URL of this page
https://metraipolis.com/documento/dc_ae3595c71be2

How to cite

Genomics-driven drug repurposing and novel targets identification for sickle cell disease in Saudi patients — Europe PMC PMID:41409427 — Europe PMC (en), https://europepmc.org/article/MED/41409427 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae3595c71be2 (Metraipolis archive dc_ae3595c71be2, sha256 cf9dce638c531b769856ee1502380e0a602de6a610d623fb767661402537e6c2)
BibTeX
@misc{dcae3595c71be2,
  title = {Genomics-driven drug repurposing and novel targets identification for sickle cell disease in Saudi patients — Europe PMC PMID:41409427},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41409427},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae3595c71be2; sha256 cf9dce638c531b769856ee1502380e0a602de6a610d623fb767661402537e6c2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41409427. Agents can read the archived copy with the MCP tool read_document.